 |
|
Hepatitis B screening rates and reactivation in solid organ malignancy patients undergoing chemotherapy in Southern Thailand
Ratchapong Laiwatthanapaisan, Pimsiri Sripongpun, Naichaya Chamroonkul, Arunee Dechaphunkul, Chirawadee Sathitruangsak, Siwat Sakdejayont, Chanon Kongkamol, Teerha Piratvisuth
Clin Mol Hepatol. 2019;25(4):366-373. Published online 2019 Jul 17 DOI: https://doi.org/10.3350/cmh.2018.0111
|
|
Citations to this article as recorded by
 Screening for viral hepatitis B infection in cancer patients before receiving chemotherapy – A systematic review and meta‐analysis
Soe Thiha Maung, Natee Deepan, Pakanat Decharatanachart, Roongruedee Chaiteerakij
Asia-Pacific Journal of Clinical Oncology.2024;[Epub] CrossRef Viral hepatitis B in patients with hematological malignancies (Overview)
Sidorkevich SV, Chebotkevich VN, Kuleshova AV, Kajtandzhan EI, Bessmeltsev SS
Archives of Hepatitis Research.2023; 9(1): 001. CrossRef Systematic review of seroprevalence of markers of hepatitis B, C and HIV among oncohematological patients
A.V. Satsuk, G.G. Solopova, A.A. Ploskireva, V.G. Akimkin
Clinical Microbiology and Antimicrobial Chemotherapy.2023; 25(2): 131. CrossRef Hepatitis B Virus Reactivation Following Treatment of HNSCC With Cisplatin
James Crosby, Forrest Smith, Subramanya Shyam Ganti, Nagabhishek Moka, Samuel Bailey
Journal of Investigative Medicine High Impact Case Reports.2022; 10: 232470962210908. CrossRef HBV seroprevalence and liver fibrosis status among population born before national immunization in Southern Thailand: Findings from a health check-up program
Supinya Sono, Jirayu Sae-Chan, Apichat Kaewdech, Naichaya Chamroonkul, Pimsiri Sripongpun, Jason T. Blackard
PLOS ONE.2022; 17(6): e0270458. CrossRef
|